Share

Search your stocks

Ctrl+K

Dipna Pharmachem Ltd.Dipna Pharmachem Ltd.

24.1(+5.93%)

1W: +20.08%

1M: +22.40%

1Y: +163.68%

Dipna Pharmachem Quarterly Results

Pros & Cons

POSITIVES

Consistent revenue growth over the past four quarters indicates strong demand for products.
Improved gross margin in the latest quarter reflects effective cost management strategies.
Increased R&D spending suggests a commitment to innovation and long-term growth.

NEGATIVES

Declining net profit margin compared to previous quarters raises concerns about profitability.
Rising operational costs may impact future earnings if not managed effectively.
Slower sales growth in the latest quarter compared to earlier periods indicates potential market saturation.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-